Information  X 
Enter a valid email address

PureTech Health PLC (PRTC)

  Print      Mail a friend

Tuesday 13 June, 2017

PureTech Health PLC

Holding(s) in Company

RNS Number : 9994H
PureTech Health PLC
13 June 2017
 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi


1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii

 

PURETECH HEALTH PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

Yes

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

No

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

No

An event changing the breakdown of voting rights

No

Other (please specify):

No

 

3. Full name of person(s) subject to the notification obligation: iii

 

 

Recordati SA Chemical and Pharmaceutical Company

 

4. Full name of shareholder(s)

(if different from 3.):iv


5. Date of the transaction and date on which the threshold is crossed or reached: v

 

12 June 2017

6. Date on which issuer notified:

13 June 2017

7. Threshold(s) that is/are crossed or reached: vi, vii

 

Below 3%


 

8. Notified details:

A: Voting rights attached to shares viii, ix

 

if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB00BY2Z0H74

9,554,140

9,554,140

0

0

0

0%

0


B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date xiii

Exercise/ Conversion Period xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights







C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

xv, xvi

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date xvii

Exercise/ Conversion period xviii

Number of voting rights instrument refers to

% of voting rights xix, xx






Nominal

Delta




Total (A+B+C)

Number of voting rights

Percentage of voting rights

0

0%


 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi



Proxy Voting:

10. Name of the proxy holder:


11. Number of voting rights proxy holder will cease to hold:


12. Date on which proxy holder will cease to hold voting rights:



 

13. Additional information:

This transfer of voting rights relates to a merger by absorption of Recordati SA Chemical and Pharmaceutical Company into Recordati S.p.A, with Recordati S.p.A as the surviving entity.

14. Contact name:

 

Silvia Signoretti

15. Contact telephone number:

 

+39 02 48787533

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLFJMFTMBABBPR

a d v e r t i s e m e n t